Harvest & Collection
PRODUCTS
-
Discover agile labeling and packaging services for pharmaceuticals, specializing in custom designs, regulatory support, and small to medium batch production with quick turnaround times.
-
MassFerence P2 calibrant for the SamuxMP and SamuxMP Auto
Ref: MP-CON-41015
-
EirGenix is a contract development and manufacturing organization that performs high quality and cost-effective services supporting our clients in development, analytical testing, and GMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing
EirGenix has strong process development capabilities in both microbial and mammalian systems to provide our clients process development, process optimization, and process troubleshooting. We have successfully delivered results to meet clients’ requirement in product productivity, product quality, and process cost effectiveness. Our previous project experience includes recombinant proteins, plasmid DNA, fusion proteins, monoclonal antibodies, and biosimilars.
-
EirGenix provides client-oriented contract development and manufacturing services for biologics, especially monoclonal antibodies and biosimilars. Combining the capabilities of EirGenix’s strategic partner, Formosa Laboratories, Inc, a high potency API manufacturer, we offer integrated services for Antibody Drug Conjugate (ADC) development and manufacturing.
-
Immunotherapy is an evolving and promising cancer treatment that works by stimulating the immune system. More biologically relevant human primary cells are now the chosen starting material for immunotherapy development. Historically, scientists routinely used immortalized cell lines in the research and development of therapies as they offer an inexpensive and stable platform. However, they are not fully representative of what is going on in vivo.
WHITE PAPERS AND CASE STUDIES
-
Unravelling Immunological Depths: Exploring Oxazolone-Induced Delayed-Type Hypersensitivity Model
Validating the oxazolone-induced DTH mouse model offers a critical platform for advancing the evaluation of therapeutic candidates for chronic inflammatory diseases, including atopic dermatitis.
-
Enhancing Clinical Supply Chain With Signant SmartSignals Supplies
A global pharma leader improved supply chain efficiency and compliance by digitalizing processes with Signant's SmartSignals Supplies, achieving better visibility, traceability, and reduced errors.
-
Large-Scale Exosome Production Stirred-Tank Bioreactors
Discover how engineered exosomes, displaying tumor-homing peptides, offer a promising tool for targeted cytotoxic drug delivery, produced efficiently with a bioreactor for critical research.
-
Innovative Water Reuse Solutions With Xylem's Advanced Treatment Technology
Transitioning to advanced purification methods like UV-hypochlorite oxidation allows municipalities to secure reliable, local water supplies. These strategies mitigate drought risks and protect coastal environments by transforming wastewater into a high-quality resource for reuse.
-
Mobile Equipment Reduces Phosphorus In Wastewater Effluent
When frigid temperatures hinder standard filtration, mobile high-rate clarification provides a rapid response to stabilize effluent quality. This approach ensures total phosphorus remains below strict permit limits during seasonal spikes without requiring long-term capital investment or infrastructure overhauls.
-
6 HUBER Coarse Screen TrashMax® For Flood Protection In Houston, Texas
In response to Hurricane Harvey, the Fort Bend, TX Levee District No. 2 embarked on a major upgrade project to increase the flow and capacity of one of its pump stations by 400%. The goal of the project was to protect the area around the district from 100- year floods in the future.
-
Transforming Clinical Trial Management
See how Vestigo® can transform your study management — streamline workflows, strengthen compliance, and eliminate inefficiencies by adopting a smarter, digital-first approach today.
-
Illumina Fortifies Supplier Relationship With Digitalization
Illumina improved its quality management by adopting digitalization, enhancing supplier collaboration and efficiency in monitoring, while transitioning from rigid manual processes to a streamlined, integrated system.
-
82 Million Gallons In. Zero PFAS Out.
Ion exchange resin is a reliable, high-capacity solution for municipal PFAS treatment, demonstrating zero detectable PFAS after processing 82 million gallons of water. The technology offers a significantly smaller footprint and superior volumetric capacity compared to GAC. Read the full case study to review performance data and strategic impacts.
-
Mobile Sterile Compounding Pharmacy USP 797/800
Learn how Germfree's 53-foot mobile cleanroom trailer ensured uninterrupted sterile drug compounding during a facility renovation.
-
Navigating Sensitive Country Requirements
See how Scout expertly navigated complex regional laws and regulations to allow study patients in Iran access to treatment in Turkey.
-
Sol-Gel Builds Awareness Of Rare Skin Condition, Generates Leads
Explore a 60-day HCP Awareness email campaign that surpassed industry benchmarks and generated a substantial number of leads.
NEWS
-
Trident IoT Unveils Revolutionary Software Development Kits For Z-Wave/ZWLR And Zigbee RF SoCs4/2/2025
Trident IoT is proud to announce the release of its highly anticipated Software Development Kits (SDKs) for its latest line of Z-Wave/ZWLR and Zigbee RF System-on-Chips (SoCs).
-
Researchers Uncover Role Of A-Site Cation Ordering In Perovskite Anodes For High-Temperature Oxygen Evolution7/28/2025
Solid oxide electrolysis cells (SOECs) are a leading technology for carbon dioxide reduction and energy conversion, offering high current densities, excellent Faradaic efficiency, and low overpotentials. Perovskite oxides are commonly used as SOEC anodes, yet the impact of A-site cation ordering on their oxygen evolution reaction (OER) kinetics remains unexplored.
-
NEOVAC Presents Innovative Vacuum Coating Technology For High-Strength Steels With No Thermal Stress8/27/2025
NEOVAC, a joint venture between SMS group GmbH and SITIZN Group Holding AG, based in Karlstein, Germany, is proud to present a brand new technology for coating steel strip, which was specially developed for high-strength and ultra-high-strength steels.
-
Solar Boost For Poland: VSB Group Wins Auction Contract For 303 MWp Solar Park In Lower Silesia7/23/2025
As part of this year’s renewable energy auction organized by the Polish Energy Regulatory Office (URE), VSB has secured a contract for difference (CfD) for a 303 megawatt-peak (MWp) solar park: the largest solar project in the history of the VSB Group to date.
-
ANDRITZ To Supply New Generators For Bridge River 1 Hydropower Plant In Canada3/11/2025
International technology group ANDRITZ has received an order from the Canadian utility BC Hydro to supply four 60 MVA generators for the Bridge River 1 hydropower plant in British Columbia.
ABOUT
Harvest and Collection
Harvest and collection is the process used to retrieve biological agents and vaccines present in cell cultures or to harvest and collect stem cells from blood or bone marrow. Many bioresearch companies have sophisticated systems for harvesting and collecting cells. These systems make counting cells easier and they also protect against contamination.
Cells are harvested once the cells reach a density level in the cell culture medium that precludes further growth. The best time to harvest cells is when they are in a confluent state (at least 50% of the culture dish is covered and before 100% of the dish is covered).
Cells can be harvested using on of three methods: Mechanical, using Proteolytic enzymes, or using EDTA. Mechanical harvesting uses a rubber spatula to remove the cells from the growth surface or culture. This method is quick but can cause many cells to die because it is highly disruptive. This method is favored when harvesting lots of different samples of cells to prepare extracts.
In this case, viability of the cells doesn’t matter. Three enzymes; Trypsin, Collagenase, and Pronase can be used in combination with EDTA. The combination of these enzymes with the EDTA makes cells detach from the growth medium.
This method is easy but also has a downside. It can damage the cell surface by eating up exposed cell surface proteins. EDTA can be used alone to detach cells from their medium and it is gentler than using trypsin.
Normally, collected cells are placed in a new suspension, or growth medium to continue growing new cultures. This is referred to as passaging or splitting the cells.